Global Bladder Scanners Market Size By Type (2D, 3D), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Bladder Scanners Market was valued at USD 142 million in 2023 and is projected to reach USD 263 million by 2031, expanding at a CAGR of 8.1% during the forecast period (2023–2031). This growth is fueled by the rising prevalence of urological disorders, increasing geriatric population, and a growing demand for non-invasive diagnostic procedures. Bladder scanners play a pivotal role in providing real-time, accurate, and safe assessment of urinary bladder volume, particularly in hospital and clinical settings. The technology enhances patient care while reducing the risks of urinary tract infections (UTIs) and catheter-associated complications.

Drivers:

1. Rising Geriatric Population and Urological Disorders: With age being a primary risk factor for urinary retention and incontinence, the increase in elderly populations worldwide significantly contributes to market demand.

2. Non-Invasive Nature of Bladder Scanners: The move toward minimally invasive diagnostic tools is propelling adoption. These devices offer a pain-free, radiation-free alternative to traditional methods, improving patient experience.

3. Hospital Protocols Favoring Ultrasound Diagnosis: Hospitals and clinics are increasingly implementing guidelines recommending bladder scanners for post-operative urinary assessment to minimize catheter use and related infections.

Restraints:

1. High Initial Cost of Devices: Bladder scanners are high-value medical devices, and their upfront costs can deter adoption in smaller or resource-limited healthcare settings.

2. Lack of Skilled Technicians: Proper interpretation of results requires trained personnel. A shortage of adequately trained operators, especially in emerging markets, may limit effective deployment.

Opportunity:

1. Untapped Markets in Emerging Economies: Healthcare infrastructure development in regions like Asia-Pacific and Latin America is creating fertile ground for expansion. As awareness grows, so does the adoption rate.

2. Integration with AI and Cloud Technology: Next-generation bladder scanners with AI-based volume estimation, real-time image sharing, and cloud storage functionalities are opening new frontiers in tele-urology and remote diagnostics.

Market by System Type Insights:

The 2D bladder scanner segment dominated the market in 2023 due to its affordability and wide availability. However, the 3D bladder scanner segment is projected to grow at the highest CAGR during the forecast period, driven by its superior imaging accuracy and clinical effectiveness in complex diagnoses.

Market by End-use Insights:

The Hospitals segment accounted for the largest market share in 2023, reflecting the widespread use of bladder scanners in acute care and post-surgical recovery settings. The Diagnostic Imaging Centers segment is anticipated to experience robust growth, propelled by increased patient referrals and outpatient urological diagnostics.

Market by Regional Insights:

North America led the global bladder scanners market in 2023, thanks to high healthcare spending, advanced hospital infrastructure, and proactive adoption of non-invasive diagnostics. Meanwhile, Asia-Pacific is expected to register the fastest growth, driven by improving healthcare access, aging populations, and increasing investment in medical technology in countries like China, India, and Japan.

Competitive Scenario:

Leading players in the global bladder scanners market include Verathon Inc., Echo-Son SA, LABORIE, Signostics, dBMEDx Inc., C. R. Bard Inc., and GE Healthcare. These companies are focused on launching portable, AI-integrated, and wireless scanner solutions. Key developments include:

2023: Verathon launched a new BladderScan i10 system with enhanced AI diagnostics for improved bladder volume measurement.

2024: dBMEDx introduced a fully automated, app-based bladder scanner aimed at point-of-care applications in emergency settings.

2025: LABORIE completed the acquisition of a startup specializing in cloud-based diagnostic platforms to enhance real-time urology imaging.

Scope of Work – Global Bladder Scanners Market

Report Metric Details

Market Size (2023) USD 142 million

Projected Market Size (2031) USD 263 million

CAGR (2023–2031) 8.1%

Market Segments System Type (2D, 3D), End-use (Hospitals, Clinics, Diagnostic Imaging Centers), Region

Growth Drivers Rise in geriatric population, non-invasive diagnostics, reduction of catheter-associated infections

Opportunities Emerging markets, AI integration, telemedicine deployment

Key Market Developments:

Verathon Inc. (2023): Released the BladderScan i10 with AI-guided measurement algorithms.

Signostics (2024): Partnered with mobile health units in rural Asia-Pacific to deploy portable bladder scanners.

LABORIE (2025): Launched integrated bladder volume tracking systems for remote monitoring in senior care facilities.

FAQs:

1. What is the current market size of the Global Bladder Scanners Market?

The Global Bladder Scanners Market was valued at USD 142 million in 2023.

2. What is the major growth driver of the Global Bladder Scanners Market?

The market is driven by the increasing elderly population and the demand for non-invasive diagnostic tools to reduce catheter-associated infections.

3. Which is the largest region during the forecast period in the Global Bladder Scanners Market?

North America holds the largest market share, while Asia-Pacific is expected to witness the highest growth rate.

4. Which segment accounted for the largest market share in the Global Bladder Scanners Market?

The Hospitals segment led the market in 2023 due to widespread adoption for post-operative urinary assessments.

5. Who are the key market players in the Global Bladder Scanners Market?

Key players include Verathon Inc., LABORIE, Echo-Son SA, Signostics, dBMEDx Inc., and GE Healthcare.